Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104926671A enables high-yield D-phenylalanine production with reduced costs and superior purity for pharmaceutical supply chains globally.
Novel patent CN115093392B details high-purity R-lipoic acid synthesis. Offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN101284797A details enzymatic resolution of N-protected allylglycinate using subtilisin crystals for high purity chiral intermediates.
Discover the enzymatic synthesis route for Nilaparib intermediates described in CN111072550A. Achieve high purity and cost efficiency in API manufacturing with our advanced catalytic technologies.
Patent CN112321613B reveals a novel route for high-purity Edoxaban Tosylate and isomers. Discover cost-effective manufacturing strategies for this critical anticoagulant API.
Novel synthesis route for diabetic drug intermediates via CN1434800A. Enhances purity and scalability for pharmaceutical manufacturing supply chains.
Patent CN101531647B details a safe resolution method for Ramelteon intermediates. Discover cost-effective supply chain solutions and high-purity manufacturing capabilities.
Novel method for beta-lactamase inhibitor intermediate chiral impurities. High purity ee>99.5%. Cost-effective supply chain solutions for pharma QC.
Patent CN103497145A details a scalable chemical resolution for high-purity donepezil. Discover cost-effective supply chain solutions and technical advantages.
Advanced lipase CALB mutant technology enables high-purity pharmaceutical intermediates manufacturing with reduced costs and enhanced supply chain reliability for global buyers.
Novel synthesis route for Alzheimer's intermediate. Eliminates column purification and chiral HPLC. Reduces cost and improves scalability for pharmaceutical manufacturing.
Patent CN1181035C enables high-purity NSAID intermediate production with reduced costs and scalable resolution processes for global supply chains.
Patent CN109628504A details a biphasic microbial resolution method. This technology enhances purity and yield for pharmaceutical intermediates while offering supply chain cost advantages.
Patent CN105063161B reveals high-purity R-1-aminoindane production. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN116024282B details enzymatic dynamic kinetic resolution for high purity S nornicotine offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107400156B details a solvent-based resolution of Antcin K epimers, offering high purity and cost-effective supply chain solutions for pharmaceutical intermediates.
Patent CN105820113B reveals a novel resolution method for Crizotinib intermediates offering high purity and scalable manufacturing for global pharmaceutical supply chains.
Novel camphorsulfonic acid resolution method for high-purity 3-amino-3-phenylpropionic acid. Reduces waste and cost for Dapoxetine intermediate manufacturing.
Patent CN102093284A details a novel racemization method for piperidine-2-carboxanilide compounds, offering significant cost reduction and supply chain reliability for API manufacturing.
Advanced patent-based synthesis of Clopidogrel Bisulfate offering high yield and purity. Cost-effective pharmaceutical intermediate manufacturing for global supply chains.